Literature DB >> 24909251

Leptin -2548g/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study.

Jizhong Shen1, Weihong Ge, Jinping Zhang, Huai Jun Zhu, Yun Fang.   

Abstract

BACKGROUND: The leptin -2548G/A (rs7799039) gene polymorphism has been implicated in susceptibility to antipsychotic-induced weight gain (AIWG), but study results are still controversial. The present meta-analysis was performed to investigate the relationship between the leptin -2548G/A gene polymorphism and AIWG.
METHODS: Electronic databases were searched for eligible articles in English and Chinese and seven separate studies on the association of the leptin -2548G/A gene polymorphism with AIWG were analyzed.
RESULTS: The meta-analysis involved 451 AIWG patients and 568 controls. The pooled odds ratio (OR) and their corresponding 95% confidence interval (CI) were calculated by a fixed or random effect. Overall, our meta-analysis suggests that the leptin -2548G/A gene polymorphism was not significantly associated with AIWG risk under various genetic models. But, in the subgroup analysis by ethnicity, significant association was found between leptin -2548A allele and the AIWG risk in Asian populations under additive, dominant, recessive, and homozygote genetic model. On the contrary, in European populations, the -2548A allele seemed to decrease the risk of AIWG when compared with the -2548G allele under various genetic models, even though they were not statistically significant.
CONCLUSION: Our meta-analysis suggests that the correlation between leptin -2548G/A gene polymorphism and AIWG risk has significant racial differences.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909251

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  10 in total

1.  Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia.

Authors:  Jonathan M Meyer; Yongcai Mao; Andrei Pikalov; Josephine Cucchiaro; Antony Loebel
Journal:  Int Clin Psychopharmacol       Date:  2015-11       Impact factor: 1.659

2.  The Impact of LEP G-2548A and LEPR Gln223Arg Polymorphisms on Adiposity, Leptin, and Leptin-Receptor Serum Levels in a Mexican Mestizo Population.

Authors:  Efraín Chavarria-Avila; Mónica Vázquez-Del Mercado; Eduardo Gomez-Bañuelos; Sandra-Luz Ruiz-Quezada; Jorge Castro-Albarran; Lizeth Sánchez-López; Beatriz Teresita Martín-Marquez; Rosa-Elena Navarro-Hernández
Journal:  Biomed Res Int       Date:  2015-05-10       Impact factor: 3.411

Review 3.  The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.

Authors:  Alex T Raben; Victoria S Marshe; Araba Chintoh; Ilona Gorbovskaya; Daniel J Müller; Margaret K Hahn
Journal:  Front Neurosci       Date:  2018-01-22       Impact factor: 4.677

4.  TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.

Authors:  Shen Li; Chengai Xu; Yuan Tian; Xueshi Wang; Rui Jiang; Miaomiao Zhang; Lili Wang; Guifu Yang; Ying Gao; Chenyu Song; Yukun He; Ying Zhang; Jie Li; Wei-Dong Li
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

5.  C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia.

Authors:  Jingping Liao; Ning Wang; Mengying Ma; Tianlan Lu; Hao Yan; Weihua Yue
Journal:  Front Psychiatry       Date:  2020-07-02       Impact factor: 4.157

Review 6.  Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?

Authors:  Francky Teddy Endomba; Aurel T Tankeu; Jan René Nkeck; Joel Noutakdie Tochie
Journal:  Lipids Health Dis       Date:  2020-02-07       Impact factor: 3.876

Review 7.  The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children.

Authors:  Mark R Libowitz; Erika L Nurmi
Journal:  Front Psychiatry       Date:  2021-03-12       Impact factor: 4.157

8.  Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.

Authors:  Xiaoni Guan; Jing Xu; Meihong Xiu; Xirong Li; Haixia Liu; Fengchun Wu
Journal:  CNS Neurosci Ther       Date:  2022-06-29       Impact factor: 7.035

9.  Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.

Authors:  Amilton Dos Santos-Júnior; Taciane Barbosa Henriques; Maricilda Palandi de Mello; Osmar Henrique Della Torre; Lúcia Arisaka Paes; Adriana Perez Ferreira-Neto; Letícia Esposito Sewaybricker; Thiago Salum Fontana; Eloisa Helena Rubello Valler Celeri; Gil Guerra-Júnior; Paulo Dalgalarrondo
Journal:  Int J Endocrinol       Date:  2016-01-06       Impact factor: 3.257

10.  Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia.

Authors:  Apichaya Puangpetch; Pornpen Srisawasdi; Weerapon Unaharassamee; Napa Jiratjintana; Somlak Vanavanan; Suweejuk Punprasit; Chalitpon Na Nakorn; Chonlaphat Sukasem; Martin H Kroll
Journal:  Pharmgenomics Pers Med       Date:  2019-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.